Roundup

Forbes Retracts Attack on Paper Showing Link Between Glyphosate and Cancer

The American business magazine, most famous for its Forbes 400 rich list, has long been the platform of choice for defending Monsanto’s products and attacking the company’s critics. It was on Forbes that article after article appeared attacking Prof Gilles-Eric Séralini’s study, which found harmful effects from Monsanto’s GMO maize and Roundup herbicide, shortly after its publication in 2012.

February 22, 2019 | Source: GM Watch | by Jonathan Matthews

Tobacco industry-linked author failed to disclose Monsanto connections

Forbes has pulled an article by Geoffrey Kabat attacking the new meta-analysis confirming a link between glyphosate and a type of cancer called non-Hodgkin lymphoma (NHL).

The American business magazine, most famous for its Forbes 400 rich list, has long been the platform of choice for defending Monsanto’s products and attacking the company’s critics. It was on Forbes that article after article appeared attacking Prof Gilles-Eric Séralini’s study, which found harmful effects from Monsanto’s GMO maize and Roundup herbicide, shortly after its publication in 2012. 

The authors of most of those hatchet jobs had links to Monsanto. Jon Entine’s PR firm, for instance, consulted for the company. Bruce Chassy made the front page of the New York Times, along with Kevin Folta, because of his remarkably close ties to Monsanto. And Henry Miller, who, along with Chassy, accused Séralini of fraud, subsequently had all his articles for Forbes pulled by the magazine after it emerged that at least one of them had been ghostwritten by Monsanto.